🇺🇸 FDA
Patent

US 8202242

Method of using vasoconstrictive agents during energy-based tissue therapy

granted A61KA61K31/00A61K31/519

Quick answer

US patent 8202242 (Method of using vasoconstrictive agents during energy-based tissue therapy) held by Covidien LP expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Covidien LP
Grant date
Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/00, A61K31/519, A61K31/522, A61K31/53